![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](cf2190contents.gif)
Acta Cryst. (2008). E64, m821 [ doi:10.1107/S1600536808014141 ]
![[mu]](/logos/entities/mu_rmgif.gif)
-acetato-![[kappa]](/logos/entities/kappa_rmgif.gif)
4O:O'-bis[2-(5-phenylisoxazolin-3-yl)phenyl-2C1,N]dipalladium(II)Abstract: The title compound, [Pd2(C15H10NO)2(C2H3O2)2], crystallized from a dichloromethane/n-hexane solution with two crystallographically independent dimeric molecules in the asymmetric unit. Each molecule may be described as a dimer with an anti configuration and the cyclometallated fragments in the characteristic open-book disposition, linked by two bridging acetate ligands.
Online 17 May 2008
Copyright © International Union of Crystallography
IUCr Webmaster